MedPath

A study to know the effect of two ayurvedic medicines namely dadruhar lepa and raktamokshana (jalaukavcharana)along with Nimba~patola patra kwath in management of dadru w.s.r to tinea

Phase 2
Conditions
Health Condition 1: B359- Dermatophytosis, unspecified
Registration Number
CTRI/2022/04/041814
Lead Sponsor
Ayurvedic and Unani Tibbia College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient willing to participate in the trial and sign the consent form.

2.The patients between the age group of 18 to 60 years in either sex.

3.Patients of Dadru with features mentioned in subjective parameters.

4.Patient already taking modern medicine (Antifungals)& Local applications.

5.Patient having Potassium hydroxide (KOH) scrapping test positive

Exclusion Criteria

1.Patients who were not willing for trial or fail to give consent.

2.Patients suffering from any other systemic illness,liver disorder, tuberculosis,bleeding disorder etc.

3.Pregnant and lactating women.

4.Patients taking antibiotic therapy for any systemic illness within 2 months.

5.H/O of hypersensitivity of any trial drug.

6.Allergic reaction to active substances of the leech such as hirudin,calin,hyaluronidase,egline,kollagenage,apyrase,destabilase,piyavit etc.

7.Patients with genetic and endocrinal disorder, chronic disorder like paralysis, cancer, renal failure, hepatic failure and IHD.

8.Patients having Tinea manuum and Tinea unguim.

9.Raktamokshana (jalaukavcharana)will not be done in Patients having diabetes mellitus.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in subjective parameters. <br/ ><br>Raga (Inflammation) <br/ ><br>Pidika (Eruption) <br/ ><br>Daha (Burning sensation) <br/ ><br>Rookshata (Dryness) <br/ ><br>Udgata mandal (Elevated lesion)Timepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
Assessment will be done clinically on basis of decrease in subjective parameters of dadruTimepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath